Senior insider sale
Chief Commercial Officer at CYTOKINETICS INC — senior position signals high conviction
$6.19M
81.19K shares
What this filing means
CALLOS ANDREW plans to sell 81.19K shares of CYTOKINETICS INC valued at approximately $6.19M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/30/2026ACC: 0001950047-26-007436
Officer· Chief Commercial Officer
Since Mar 2021
81.19K
Shares to sell
$6.19M
Approx. market value
24K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/30/2026
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/30/2026 | Exercise of Stock Options Cash | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
15K
Market value
$1.29M
6/30/2026
—Completed
Units to sell
15K
Market value
$1.11M
6/1/2026
—Completed
Units to sell
11.33K
Market value
$875.5K
5/5/2026
—Completed
Units to sell
15.86K
Market value
$1.03M
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24K
Market value
$1.88M
7/30/2026
Total
Units
81.19K
Value
$6.19M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2026 | 15K | $1.29M | — | Completed |
6/1/2026 | 15K | $1.11M | — | Completed |
5/5/2026 | 11.33K | $875.5K | — | Completed |
5/1/2026 | 15.86K | $1.03M | — | Completed |
| Planned — Approximate Date | ||||
7/30/2026 | 24K | $1.88M | NASDAQ | Planned |
| Total | 81.19K | $6.19M | ||